SBRA
Sabra Health Care REIT, Inc.
NASDAQ · Real Estate · REIT - Healthcare Facilities · US
$21.05
+3.45%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 919.1M | 774.6M | 703.2M | 647.5M | 624.8M |
| Cost of Revenue | 361.3M | 271.1M | 227.1M | 195.2M | 162.6M |
| Gross Profit | 557.8M | 503.5M | 476.1M | 452.3M | 462.2M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 63.2M | 53.7M | 50.1M | 47.5M | 39.6M |
| General & Admin Expense | 63.2M | 53.7M | 50.1M | 47.5M | 39.6M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 358.7M | 185.9M | 169.1M | 183.1M | 187.8M |
| Total Operating Expenses | 421.9M | 239.7M | 219.1M | 230.6M | 227.4M |
| Cost and Expenses | 783.2M | 510.8M | 446.2M | 425.8M | 390.0M |
| Operating Income (EBIT) | 135.9M | 263.9M | 257.0M | 221.7M | 234.8M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 116.3M | 112.5M | 115.3M | 113.0M | 105.5M |
| Net Interest Income | (116.3M) | (112.5M) | (115.3M) | (113.0M) | (105.5M) |
| Other Non-Op Income/Expense | (64.8M) | (106.5M) | (129.3M) | (206.0M) | (311.2M) |
| Non-Operating Income (excl Interest) | (51.5M) | (6.0M) | 14.0M | 93.0M | 205.7M |
| EBT (Pre-Tax Income) | 71.1M | 157.3M | 127.7M | 15.8M | (76.4M) |
| Income Tax Expense | 1.8M | 1.8M | 1.0M | 2.0M | 1.2M |
| Bottom Line | |||||
| Net Income | 71.5M | 155.6M | 126.7M | 13.8M | (77.6M) |
| Earnings from Cont. Ops | 69.4M | 155.5M | 126.7M | 13.8M | (77.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 71.5M | 155.6M | 126.7M | 13.8M | (77.6M) |
| Per Share | |||||
| Basic EPS | $0.28 | $0.64 | $0.54 | $0.06 | ($0.34) |
| Diluted EPS | $0.28 | $0.64 | $0.54 | $0.06 | ($0.34) |
| Revenue Per Share | $3.60 | $3.21 | $3.01 | $2.80 | $2.71 |
| Shares | |||||
| Basic Shares Outstanding | 255.6M | 241.3M | 233.5M | 231.2M | 230.9M |
| Diluted Shares Outstanding | 259.8M | 244.5M | 236.0M | 232.8M | 230.9M |
| Profitability Metrics | |||||
| EBITDA | 413.1M | 456.8M | 412.6M | 311.8M | 216.9M |
| D&A | 225.7M | 187.0M | 169.6M | 183.1M | 187.8M |
| EBIT | 187.4M | 269.8M | 243.0M | 128.7M | 29.1M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026